Navigation Links
Raptor Pharmaceuticals Raises $5 Million
Date:8/25/2009

NOVATO, Calif., Aug. 25 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has raised an aggregate $5 million of gross proceeds through a private placement of units ("August 2009 Private Placement") and through the exercise of warrants (the "Warrant Exchange") originally issued in connection with its May/June 2008 private placement. The August 2009 Private Placement resulted in gross proceeds to Raptor of approximately $2.4 million or $2.3 million after placement agent fees and other expenses. The Warrant Exchange raised approximately $2.6 million in net proceeds for Raptor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Raptor intends to use the net proceeds to fund programs for its late-stage drug product candidates and to execute its corporate strategy, including closing the proposed merger with TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX), which is expected to close in the fourth quarter of 2009.

The August 2009 Private Placement consisted of the sale of an aggregate 7,456,250 units, with each unit priced at $0.32. Each unit consists of one share of the Company's common stock and a two-year warrant to purchase one-half of one share of the Company's common stock. The units sold represent an aggregate of 7,456,250 shares of the Company's common stock and warrants ("Warrants") to purchase up to 3,728,125 shares of the Company's common stock. The Warrants are exercisable for up to two years from the date of issuance at $0.60 per share and $0.75 per share during the first and second years following issuanc
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
2. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy
5. Glendale Raptors Join Four Points by Sheraton Denver Southeast and Animal Planets Dr. Kevin Fitzgerald for Second Annual Halloween Costume Drive & Halloween Party for Kunsberg School at National Jewish Medical and Research Center
6. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
7. Smith & Nephew Endoscopys OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
8. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
9. Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference
10. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Citi Bike has come to New York City in a ... know for sure how many patients will choose to take advantage ... option. In fact, he’s happy about anything that might help ... more convenient for them to visit his office at 133 East ... Medicine at Back and Body Medical and an experienced NYC ...
(Date:6/19/2013)... 19, 2013 According to a June 17, ... Sunburn,” it is not uncommon for a person to suffer ... A person is likely to forget to reapply sunscreen properly ... both dry and itchy. When this occurs, it is essential ... , “Most people do not realize that milk contains proteins, ...
(Date:6/19/2013)... in emergency medicine and trauma surgery have had ... the days immediately after major injuries, including burns. ... their injuries now are at greatest risk from ... known as sepsis or from inflammation-induced multiorgan ... General Hospital (MGH) investigators that measures the movement ...
(Date:6/19/2013)... 2013) In what is believed to be the ... form of hereditary dystonia a movement disorder that ... brain stimulation report good success rates and lasting benefits. ... Disorders Program at Cedars-Sinai Medical Center,s Department of Neurology, ... of Neurosurgery at Beth Israel Deaconess Medical Center in ...
(Date:6/19/2013)... 2013) The results of three important studies have ... , official journal of the Congress of Neurological ... Lippincott Williams & Wilkins , a part of ... continuous "machine learning" using artificial neural networks (ANNs) may ... advanced brain cancers. Another study in the June ...
Breaking Medicine News(10 mins):Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Skin Care – How to treat Sunburn 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3
... Coalition for,Pulmonary Fibrosis (CPF) announced the appointment of ... has more than 25 years of experience,overseeing all ... in,leadership for non-profit foundations such as the CPF. ... including expanding CPF fundraising,capabilities and driving its overall ...
... Assume Key Management Posts as Senior Vice Presidents, ... (NYSE: AGP ) today announced the hiring ... key management positions: Linda,Whitley-Taylor has been named Executive ... AMERIGROUP as Senior Vice President, Senior,Litigation Counsel; and ...
... Robert A Weinberg is the first recipient of the science ... Georg and Eva Klein. The prize is awarded in person ... 29 January 2008. The prizewinner, who is to be a ... to Karolinska Institutet in Stockholm for two weeks to give ...
... In today,s volatile business,environment, unforeseen market shifts ... product forecasts, sales strategies and,development plans. By ... a high-functioning Competitive Intelligence group,can alert organizations ... warn,them about potential external risks., Competitive ...
... Collaboration with Harvard Medical International Provides ... Vital Global Health Information, BALTIMORE, Jan. 29 ... reach of their groundbreaking MEDEX,360m partnership with the launch ... and leisure travelers., Like the original MEDEX 360m ...
... side by side to equal the width of a human ... for administering medicines and other therapeutic agents to patients. But ... after they discharge their medical payloads has been a major ... months tracking the tiny tubes inside mice, have found some ...
Cached Medicine News:Health News:CPF Appoints Mishka Michon Chief Executive Officer 2Health News:AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services 2Health News:AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services 3Health News:Building and Sustaining Impactful Competitive Intelligence Organizations for Pharma 2Health News:MEDEX / Harvard Partnership Now Offers Affordable, New Intelligence to Individual Business & Leisure Travelers 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 3
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... ) today announces a licensing agreement granting Suzhou ... develop and manufacture siRNA therapeutics in ... technology.  Ribo will formulate proprietary siRNA molecules in ... platform designed to address human diseases with high ...
(Date:6/19/2013)... , June 19, 2013 Today ... solutions, introduced the next-generation of its Employer ... allows health plans to provide their employer groups ... health factors, medical and prescription drug claims, network ... (Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer ...
(Date:6/19/2013)... INDIANAPOLIS , 19. Juni 2013 ... bekannt, dass mit der Entwicklung von ... bahnbrechender Schritt in der Beschichtung mit ... die Vorteile von biokompatiblem Parylene mit ... effektive Beseitigung schädlicher Mikroorganismen auf beschichteten ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... the journal Blood found 92 percent reduction in ... ... Patients with a rare,blood disorder called PNH experienced a 92 ... treatment,with Soliris(TM) (eculizumab), according to an analysis of clinical studies,recently ...
... Groundbreaking 2002 ... ... study reveals that,coiling, a minimally invasive procedure to treat aneurysms in ... treatment in those aneurysms considered "untouchable" by the,traditional surgical option. One ...
Cached Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3
... CVA for CELL-DYN are assayed linearity control ... and to verify patient reportable range of ... also measure the linear performance of the ... have customized ranges appropriate for each instrument ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
... Proprietary EX.P.R.T. Release ... jumping,, No stent shortening,, Unique anatomically ... in the carotid bifurcation,, 0.014 Rapid ... crossing profile and flexible atraumatic tip,, ...
... Para 5X is a whole blood ... Pentra 60C+, 80 and 120, and the ... product offers a unique white cell differential, ... the algorithms on the systems. The product ...
Medicine Products: